Jane Street Group, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 85,361 shares of LXRX stock, worth $70,849. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,361

Previous 129,856 34.26%

Holding current value

$70,849

Previous $218,000 38.53%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.51 - $2.39 $67,187 - $106,343	-44,495 Reduced 34.26%	85,361 $134,000
Q2 2024 Aug 14, 2024	SELL	$1.54 - $2.28 $233,667 - $345,948	-151,732 Reduced 53.88%	129,856 $218,000
Q1 2024 May 15, 2024	BUY	$1.3 - $3.58 $11,987 - $33,011	9,221 Added 3.39%	281,588 $675,000
Q4 2023 Feb 14, 2024	BUY	$1.0 - $1.53 $190,437 - $291,368	190,437 Added 232.44%	272,367 $416,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $65,064 - $143,020	61,382 Added 298.72%	81,930 $89,000
Q2 2023 Aug 14, 2023	SELL	$2.15 - $3.49 $49,396 - $80,182	-22,975 Reduced 52.79%	20,548 $47,000
Q1 2023 May 15, 2023	BUY	$1.99 - $2.68 $52,122 - $70,194	26,192 Added 151.13%	43,523 $105,000
Q4 2022 Feb 14, 2023	SELL	$1.8 - $2.56 $30,978 - $44,057	-17,210 Reduced 49.82%	17,331 $33,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $67,009 - $118,475	34,541 New	34,541 $83,000
Q2 2022 Aug 16, 2022	SELL	$1.31 - $2.69 $25,837 - $53,054	-19,723 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.95 - $3.89 $36,550 - $72,914	-18,744 Reduced 48.73%	19,723 $41,000
Q4 2021 Feb 15, 2022	SELL	$3.81 - $6.16 $4,773 - $7,718	-1,253 Reduced 3.15%	38,467 $152,000
Q3 2021 Nov 16, 2021	BUY	$3.38 - $5.35 $82,840 - $131,123	24,509 Added 161.13%	39,720 $191,000
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $30,755 - $43,819	-7,465 Reduced 32.92%	15,211 $70,000
Q1 2021 May 18, 2021	BUY	$3.45 - $9.09 $78,232 - $206,124	22,676 New	22,676 $133,000
Q4 2020 Feb 17, 2021	SELL	$1.05 - $3.67 $12,611 - $44,080	-12,011 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$1.44 - $2.1 $8,835 - $12,885	-6,136 Reduced 33.81%	12,011 $17,000
Q2 2020 Aug 17, 2020	BUY	$1.75 - $2.3 $31,757 - $41,738	18,147 New	18,147 $36,000
Q1 2020 May 15, 2020	SELL	$1.8 - $4.28 $25,183 - $59,881	-13,991 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $149,073 - $242,951	-47,175 Reduced 77.13%	13,991 $58,000
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $73,399 - $407,365	61,166 New	61,166 $184,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Lexicon Pharmaceuticals, Inc. Transaction History